References
1. Lazowska-Przeorek I, Kakol D, Karolewska-Bochenek K, Banaszkiewicz A.
“Cobblestone” Appearance of Esophagus: An Unusual Symptom of Pyloric
Stenosis. Journal of Pediatric Gastroenterology and Nutrition.
2017;65(5):e110.
2. Zimmer V, Emrich K. Cobblestone esophagus in eosinophilic
esophagitis. Advances in Digestive Medicine. 2023;10(1):58-9.
3. Jang KM, Lee KS, Lee SJ, Kim EA, Kim TS, Han D, Shim YM. The spectrum
of benign esophageal lesions: imaging findings. Korean J Radiol.
2002;3(3):199-210.
4. Yang GD, Lu PX, Qin J, Liu ST, Zhan NY. Radiologic diagnosis for AIDS
patients complicated with candidal esophagitis. Chin Med J (Engl).
2011;124(7):965-7.
5. De Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm
D, et al. Esophagitis Associated with the Use of Alendronate. New
England Journal of Medicine. 1996;335(14):1016-21.
6. Yamamoto K, Kishino M, Nakamura S, Tokushige K. Symptoms and Upper
Gastrointestinal Mucosal Injury Associated with Bisphosphonate Therapy.
Intern Med. 2019;58(8):1049-56.
7. Abdi S, Masbough F, Nazari M, Abbasinazari M. Drug-induced
esophagitis and helpful management for healthcare providers.
Gastroenterol Hepatol Bed Bench. 2022;15(3):219-24.
8. Goldberg HI, Dodds WJ. Cobblestone esophagus due to Monilial
infection. Am J Roentgenol Radium Ther Nucl Med. 1968;104(3):608-12.
9. Kim SH, Jeong JB, Kim JW, Koh SJ, Kim BG, Lee KL, et al. Clinical and
endoscopic characteristics of drug-induced esophagitis. World J
Gastroenterol. 2014;20(31):10994-9.
10. Cryer B, Bauer DC, editors. Oral bisphosphonates and upper
gastrointestinal tract problems: what is the evidence? Mayo Clinic
Proceedings; 2002: Elsevier.